MEDEKERS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDEKERS
Largest movements
- Receivables within one year -€34,589
down €34,589 (-56.4%), from €61,326 to €26,737
of which Trade receivables: -€36,000
- Tangible fixed assets -€6,875
down €6,875 (-7.5%), from €91,458 to €84,583
- Other debts -€38,170
down €38,170 (-26.8%), from €142,558 to €104,388
- Profit (loss) carried forward -€5,491
down €5,491 (-7.9%), from -€69,800 to -€75,291
- Gross operating margin -€34,403
down €34,403 (-90.5%), from €38,022 to €3,619
- Financial charges -€416
down €416 (-13.8%), from €3,001 to €2,585
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €152,838 | €111,463 | -€41,375 | -27.1% |
| Fixed assets | 21/28 | €91,458 | €84,583 | -€6,875 | -7.5% |
| Tangible fixed assets | 22/27 | €91,458 | €84,583 | -€6,875 | -7.5% |
| Land and buildings | 22 | €91,458 | €84,583 | -€6,875 | -7.5% |
| Current assets | 29/58 | €61,380 | €26,880 | -€34,500 | -56.2% |
| Amounts receivable within one year | 40/41 | €61,326 | €26,737 | -€34,589 | -56.4% |
| Trade receivables | 40 | €36,000 | €0 | -€36,000 | -100% |
| Other amounts receivable | 41 | €25,326 | €26,737 | +€1,411 | +5.6% |
| Cash at bank and in hand | 54/58 | €54 | €143 | +€89 | +167% |
| Total equity and liabilities | 10/49 | €152,838 | €111,463 | -€41,375 | -27.1% |
| Equity | 10/15 | €10,280 | €4,789 | -€5,491 | -53.4% |
| Contributions | 10/11 | €80,000 | €80,000 | = | 0.0% |
| Reserves | 13 | €80 | €80 | = | 0.0% |
| Distributable reserves | 133 | €80 | €80 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€69,800 | -€75,291 | -€5,491 | -7.9% |
| Amounts payable | 17/49 | €142,558 | €106,674 | -€35,884 | -25.2% |
| Amounts payable within one year | 42/48 | €142,558 | €106,674 | -€35,884 | -25.2% |
| Trade debts | 44 | €0 | €760 | +€760 | |
| Suppliers | 440/4 | €0 | €760 | +€760 | |
| Taxes, remuneration and social security | 45 | - | €1,526 | +€1,526 | |
| Taxes | 450/3 | - | €1,526 | +€1,526 | |
| Other amounts payable | 47/48 | €142,558 | €104,388 | -€38,170 | -26.8% |
| Non-recurring operating income | 76A | €3,146 | €0 | -€3,146 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,875 | €6,875 | = | 0.0% |
| Other operating charges | 640/8 | €1,015 | €1,061 | +€47 | +4.6% |
| Gross operating margin | 9900 | €38,022 | €3,619 | -€34,403 | -90.5% |
| Operating profit (loss) | 9901 | €30,132 | -€4,317 | -€34,449 | |
| Financial income | 75/76B | €1,490 | €1,411 | -€79 | -5.3% |
| Recurring financial income | 75 | €1,490 | €1,411 | -€79 | -5.3% |
| Financial charges | 65/66B | €3,001 | €2,585 | -€416 | -13.8% |
| Recurring financial charges | 65 | €3,001 | €2,585 | -€416 | -13.8% |
| Profit (loss) for the period before taxes | 9903 | €28,622 | -€5,491 | -€34,113 | |
| Profit (loss) for the period | 9904 | €28,622 | -€5,491 | -€34,113 | |
| Profit (loss) for the period to be appropriated | 9905 | €28,622 | -€5,491 | -€34,113 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.